Patient-related outcome measurements in pleural diseases

Ioannis Psallidas (Oxford, United Kingdom), Ioannis Psallidas, Talwar Ambika, John P. Corcoran, Eleanor K. Mishra, Rob J. Hallifax, John Wrightson, Najib M. Rahman

Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Session: Malignant pleural effusions and mesothelioma
Session type: Thematic Poster Session
Number: 4342
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ioannis Psallidas (Oxford, United Kingdom), Ioannis Psallidas, Talwar Ambika, John P. Corcoran, Eleanor K. Mishra, Rob J. Hallifax, John Wrightson, Najib M. Rahman. Patient-related outcome measurements in pleural diseases. Eur Respir J 2015; 46: Suppl. 59, 4342

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Pleural effusions after cardiac surgery: Etiology and outcomes
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016


Clinical characteristics and outcomes of pleural empyema in Southern Tunisia
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT)
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018



Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Comorbidities associated with sarcoidosis – Results from long-term observational study
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Clinical and prognostic scores in patients with cancer and pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

An review of infection rates of invasive pleural procedures
Source: International Congress 2016 – Pleural diseases
Year: 2016


Clinic and radiologic features and outcomes of amidrone induced alveolities under the influence of steroid treatment
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015


Efficacy and safety of a new pleural device for the ambulatory management of pneumothorax
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015


Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP)
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Main and additional predictors of COPD progression
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Bronchial anthracosis-anthracofibrosis: Potential causes and clinical features
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013


Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016


Prediction of complications after pneumonectomy in patients with pulmonary tuberculosis
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015


Diagnosis and management of pneumothorax: An audit of local prevalence, aetiology and adherence to national guidelines
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013